Pharmacodynamic Study of Estrogen Suppression Threshold-Directed Therapy (ESTDT) of Anastrozole as Adjuvant Therapy for Early Stage Breast Cancer
Latest Information Update: 30 Jan 2025
At a glance
- Drugs Anastrozole (Primary) ; Letrozole (Primary)
- Indications Carcinoma; Early breast cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 14 Sep 2023 Status changed from active, no longer recruiting to completed.
- 12 Jun 2023 Planned primary completion date changed from 1 Jun 2023 to 31 Jan 2024.
- 12 Jun 2023 Status changed from recruiting to active, no longer recruiting.